summary: It is known that beta-interferon reduces relapses by a third. The authors investigated the effect that it has on reducing inflammation on MRI in people with MS. They found that MRI activity was actually reduced by a half.

authors: Chiu AW, Richert N, Ehrmantraut M, Ohayon J, Gupta S, Bomboi G, Gaindh D, Cantor FK, Frank JA, McFarland HF, Bagnato F

source: Arch Neurol. 2008 Nov 10. [Epub ahead of print]

weblink: click here

category: Imaging

related research news: click here

glossary: